Crimean-Congo hemorrhagic fever (CCHF) is caused by infection with a tick-borne virus and is characterized by hemorrhagic manifestations and high fatality. CCHF is endemic in Africa, Asia, Middle East, Russia, and Balkans (1) . Malaria is a parasitic disease that remains one of the greatest causes of morbidity and mortality in the tropical and subtropical regions of the world. Annually, approximately 85z of clinical malaria cases and 90z of deaths due to malaria are observed in Africa (2) . Here, we report a case of a Bulgarian patient with imported falciparum malaria acquired in Africa and autochthonous CCHF. Bulgaria, located in southeast Europe, is endemic for CCHF but not for malaria. In the last 3 years (2011-2013), a total of 17 cases of CCHF and 26 cases of imported malaria have been registered in the country.
A 39-year-old male resident of Krumovgrad (Kardzhali district, South Bulgaria), an area known to be endemic for CCHF, was hospitalized on March 26, 2013, with 1-day sudden onset of fever (38.5-399 C), headache, and myalgia. The patient's temperature returned to normal the next day, but his condition deteriorated on March 28, with vomiting and bloody diarrhea apart from fever. The main laboratory findings were extreme thrombocytopenia (platelet count, 8 × 10 9 /L; normal range, [150-400] × 10 9 /L), leucocytosis (leukocyte count, 11.6 × 10 9 /L; normal range, [3.5-10.3 ] × 10 9 /L), and elevated levels of liver enzymes. Physical examination revealed conjunctival injection, hyperemic tonsils and pharynx as well as skin suffusions and ecchymoses; the patient retained consciousness with normal neurological status. Because the patient had returned from Zambia on March 20, 2013, a blood smear was inspected on March 30, which revealed high parasitemia (224,000/mL), with annular forms and gametocytes of Plasmodium falciparum. In addition, RNA of the CCHF virus was detected by real-time reverse transcription (RT)-PCR (3), which revealed a viral load of 1.3 × 10 4 copies/mL of blood sample, and nested RT-PCR (4); these assays were performed using the same blood sample on the same day. Antibodies against the CCHF virus were not detectable in the patient's serum, which is reasonable given the very early stage of the infection. The obtained sequence (GenBank accession no. KJ000206) was found to be clustered within the Europe 1 lineage, which also includes the respective sequences from the Balkans and Russia (Figure 1 ). Sequence analysis also revealed highest similarity (99.5z at nucleotide level) with sequences obtained from human CCHF cases in 2002-2003 in Haskovo, a neighboring district of Kardzhali.
On admission, specific therapy for CCHF and malaria was administered; CCHF-bullin (hyperimmunoglobulin obtained from volunteers immunized with Bulgarian CCHF vaccine, Bulbio-NCIPD, Sofia, Bulgaria) 18 mL per day through intramuscular route, and artequine (artesunate 200 mg plus mefloquine 250 mg) orally, replaced later with artesunate 240 mg intramuscularly (i.m.) on the first day, followed by 120 mg i.m. per day on subsequent days of hospitalization. In addition, the patient received platelet concentrate, fresh frozen plasma, ceftriaxone, and levofloxacin every day ( Table 1) .
The specific therapy for malaria was successful as the level of the parasitemia dropped rapidly to 36,000/mL on April 3, and further, to 1,000/mL on April 6. However, the CCHF hemorrhagic manifestations became severe, with epistaxis, melena, and hemoptysis. The patient's condition gradually worsened from March 30, with the development of psychomotor agitation and impaired consciousness. Urea and creatinine levels gradually increased to 153.2 mg/dL and 4.6 mg/dL (normal range, 22.4 mg/dL and 1.4 mg/dL), respectively, on April 3. Despite the ongoing treatment, the patient manifested respiratory distress (respiratory acidosis) and circulatory collapse, and died on April 7 (Table 1) . Strain of the present study is marked.
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According to the World Health Organization guidelines (5), the patient was classified as suffering from severe malaria due to invasion of 5z of the erythrocytes by P. falciparum (parasitemia of 100,000/mL), and development of renal impairment, pulmonary edema, impaired consciousness, and circulatory collapse. Artesunate intravenously administration is typically the first recommendation for the treatment of severe malaria (6) . In the present case, the typical frequency of malaria attacks was not observed; this, however, is not Fatal Outcome of Coinfection of CCHF and Malaria an exception in falciparum malaria. In the present case, malaria is likely to have been a non-acute infection. The patient worked as a driller in an oil station in South Zambia since January, where he was hospitalized and treated for malaria during the same month according to his medical history. Despite the treatment, the patient experienced a few febrile episodes in the next few months of his stay in Zambia. The detection of both annular forms and gametocytes of P. falciparum in the patient's blood smear could be an indication of reinfection or recrudescence of malaria. The first febrile episode in Bulgaria was presumably due to malaria, while the next 8 days after his arrival in Bulgaria was accompanied by bloody diarrhea and attributable to the CCHF onset. Potential risk factors from epidemiological anamnesis included residence in a CCHF endemic area and contact with livestock. The patient failed to notice any tick bites.
It is well known that hosts infected with Plasmodium spp. are immunosuppressed, which makes them prone to infections with other microorganisms (7) (8) (9) (10) . In the present case, the patient's immunosuppressed status probably facilitated infection with the CCHF virus.
In addition, the coinfection of malaria and CCHF was possibly more severe than either of the single infections, as established for the coinfection of malaria and dengue (11) . A retrospective matched-pair analysis conducted in French Guiana on 104 cases of dengue and malaria coinfection revealed that concurrent dengue and malaria infection tended to be more severe than the corresponding single infections (11) . Similar studies on concurrent malaria and CCHF are not available. Nevertheless, the clinical course of the present case, with multiple malarial febrile episodes which were well-tolerated over a few months' duration and the fatal end following coinfection with relatively mild CCHF, as illustrated by the low viral load, indicates a similar correlation.
Two infectious diseases may appear with many similar symptoms which are difficult to distinguish. Accordingly, the clinical manifestations in the present case were attributable to both malaria and CCHF. This case report therefore emphasizes yet again the importance of differential diagnosis in patients with fever and bleeding (12) .
Another specific characteristic of the present case was that malaria was easier to treat than CCHF. In fact, the level of parasitemia decreased in response to the specific treatment; however, the patient died with typical symptoms of severe CCHF hemorrhage.
The potential risk of CCHF and malaria coinfection exists in regions endemic for both the infections, as also for travelers returning from tropical and subtropical countries to CCHF endemic areas. The frequency of such coinfections is likely to be greater than reported, necessitating better awareness among healthcare workers.
